Stay updated on Pembrolizumab Combo in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.
Latest updates to the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a note in the Publications section stating that publications are provided voluntarily by the person entering information about the study (rev. 3.3.2). Removed the previous note about voluntary publication of study results (rev. 3.2.0).SummaryDifference0.1%
- Check26 days agoChange DetectedRemoved the government funding notice about potential delays and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check48 days agoChange DetectedNo content additions or deletions were detected between the two screenshots; the page content and structure remain the same, with only minor rendering differences.SummaryDifference0.3%
- Check70 days agoChange Detected- Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference2%
- Check77 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content appears to be altered.SummaryDifference0.1%
- Check92 days agoChange DetectedLocation naming was updated to 'Tatarstan, Respublika' and 'Kazan, Tatarstan, Respublika, Russia, 420029' with a full country/postal context. The revision tag changed from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.3%
Stay in the know with updates to Pembrolizumab Combo in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.